Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Disrupting ion channel scaffolding to treat neuropathic pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders and Stroke. $1,901,925. 9/1/2019-3/1/2024.
  • Prenatal Tobacco and Cannabis Exposure: A Translational Study. Panayotis Thanos (Co-Principal Investigator). NIDA. $690,000. 10/1/2018-9/1/2023.
  • Prenatal ethanol exposure and nitric oxide signaling in serotonin neurons. Samir Haj-Dahmane (Principal Investigator), Roh-Yu Shen (Co-Investigator). NIH. $1,794,375. 9/1/2018-8/1/2023.
  • Prenatal ethanol exposure and nitric oxide signaling in serotonin neurons. Samir Haj-Dahmane (Principal Investigator), Roh-Yu Shen (Co-Investigator). NIH. $1,794,375. 9/1/2018-8/1/2023.
  • Prenatal ethanol exposure on executive function. Samir Haj-Dahmane (Co-Investigator), Roh-Yu Shen (Principal Investigator). NIH. $1,794,375. 6/1/2018-3/1/2023.
  • Prenatal ethanol exposure on executive function. Samir Haj-Dahmane (Co-Investigator), Roh-Yu Shen (Principal Investigator). NIH. $1,794,375. 6/1/2018-3/1/2023.
  • Muscarinic Receptor Type 3 Regulation of Oligodendrocyte ProgenitorDifferentiation. Fraser Sim (Principal Investigator). NIH/NINDS. $1,744,530. 12/1/2017-11/1/2022.
  • Voltage-gated calcium channels in reactive astrocytes, a possible therapeutic target to reduce brain inflammation and promote remyelination in MS. Pablo Paez (Principal Investigator). National Multiple Sclerosis Society. $507,000. 4/1/2019-3/1/2022.
  • Enabling Access To Cutting-Edge Biomedical And Behavioral Science. Margarita Dubocovich (Principal Investigator). NIH. $2,117,911. 3/1/2017-12/1/2021.
  • Targeting extracellular sulfatases to accelerate oligodendrocyte progenitor-based myelin repair and regeneration. Fraser Sim (Principal Investigator). National Multiple Sclerosis Society. $579,900. 10/1/2017-9/1/2021.
  • The role of the AP2 adaptor complex in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders and Stroke. $426,725. 4/1/2019-3/1/2021.
  • Synaptic transport of endocannabinoids in the brain. Samir Haj-Dahmane (Principal Investigator). NIH. $679,145. 3/1/2020-2/1/2021.
  • Role of inhibitory GABA Projections from the Ventral Tegmental Area in Motivation Learning. Caroline Bass (Principal Investigator). Whitehall Foundation. $225,000. 1/1/2018-12/1/2020.
  • Fatty Acid Binding Protein - Mediated Control of Endocannabinoid Signaling and Drug Addiction. Panayotis Thanos (Co-Principal Investigator). NIDA. $250,000. 3/1/2018-3/1/2020.
  • Fatty acid binding protein-mediated control of endocannabinoid signaling and addiction. Samir Haj-Dahmane (Principal Investigator). NIH. $426,635. 3/1/2018-2/1/2020.
  • Targeted chemogenetic stimulation of rat VTA GABA neurons in cocaine extinction and reinstatement. Caroline Bass (Principal Investigator). National Institute on Drug Abuse. $413,625. 9/1/2017-8/1/2019.
  • Gastric Bypass, Brain Activity. Panayotis Thanos (Principal Investigator). NY Research Foundation. $30,000. 9/1/2018-8/1/2019.
  • Cocaine-induced neuroplasticity:a new role for TGF beta signaling. David Dietz (Principal Investigator). NIDA. $1,250,000. 6/1/2014-5/1/2019.
  • iSEED – Institute of Strategic Enhancement of Educational Diversity. Margarita Dubocovich (Co-Principal Investigator). UB Office of the Provost-3E Fund. 6/1/2013-5/1/2019.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). NIH, National Institute of Neurological Disorders and Stroke. $1,742,160. 6/1/2013-5/1/2019.